Sanders Demands Probe of Push to Give Company Patent for Public-Funded Cancer Treatment

  • 📰 commondreams
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

The Senate HELP Committee chair noted that 'the apparent abuse of the system... is so egregious that it has been characterized as a 'how-to-become-a-billionaire program run by the NIH.''

U.S. Sen. Bernie Sanders on Monday called for an inspector general investigation into an effort to grant a company tied to an ex-government employee an exclusive patent license for a cancer treatment produced with public resources, as revealed last week by The American Prospect.Sanders , who chairs the Senate Health, Education, Labor, and Pensions Committee, demanded a probe of the National Institutes of Health patent proposal in a letter to Christi Grimm, inspector general of the U.S.

While Love presumes that Hinrichs is either the creator of Scarlet TCR or one of its principal executives, the NIH would not confirm Hinrichs' role to Love, and offered essentially no information about the company. The Prospect attempted to contact the NIH about Scarlet TCR and Hinrichs as well, and did not receive a response. Hinrichs also did not respond to a request for comment.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 530. in BUSİNESS

Business Business Latest News, Business Business Headlines